Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Performant Healthcare Inc. has reported solid financial growth and operational performance in the first quarter of 2025.</li>
<li>Total revenues increased by 22% year-over-year to $33.3 million, a result driven by substantial expansion in both the healthcare and commercial sectors.</li>
<li>The company reported a positive adjusted EBITDA of $3.3 million, which marks a significant turnaround from the adjusted EBITDA loss of $1.2 million recorded in the same period the previous year.</li>
</ul>


Performant Healthcare Inc. has reported solid financial growth and operational performance in the first quarter of 2025.
Total revenues increased by 22% year-over-year to $33.3 million, a result driven by substantial expansion in both the healthcare and commercial sectors.
The company reported a positive adjusted EBITDA of $3.3 million, which marks a significant turnaround from the adjusted EBITDA loss of $1.2 million recorded in the same period the previous year.


Performant’s $670 Million Payday: What Machinify Isn’t Telling You!

United States

Performant Financial Corporation was founded in 2003. The company's line of business includes providing management services on a contract or fee basis.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Performant Financial (PFMT US)

Performant’s $670 Million Payday: What Machinify Isn’t Telling You!

The company reported a positive adjusted EBITDA of $3.3 million, which marks a significant turnaround from the adjusted EBITDA loss of $1.2 million...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)